CIK 0001130598 · Non-accelerated filer<br>Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-15 | Clarke Trafford Director | Grant or award · Stock Option (right to purchase) | +100,000 | 100,000 | ||
| 2022-12-15 | Atadja Peter Director | Grant or award · Stock Option (right to purchase) | +100,000 | 100,000 | ||
| 2022-08-18 | STOVER JACK E Director | Grant or award · Stock Option (right to purchase) | +66,468 | 66,468 | ||
| 2022-08-18 | MARINO JAMES J Director | Grant or award · Stock Option (right to purchase) | +66,468 | 66,468 | ||
| 2022-08-18 | MEHTA VIREN Director | Grant or award · Stock Option (right to purchase) | +66,468 | 66,468 | ||
| 2022-08-18 | Shoemaker Mary Teresa Director | Grant or award · Stock Option (right to purchase) | +66,468 | 66,468 | ||
| 2022-08-18 | GROOPMAN JEROME Director | Grant or award · Stock Option (right to purchase) | +66,468 | 66,468 | ||
| 2022-08-03 | Guerin Mark Patrick CFO AND COO | Shares withheld for taxes | −1,355 | $1.32 | $2K | 13,076 |
| 2022-08-03 | Gelder Mark S. MD CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,135 | $1.32 | $1K | 5,896 |
| 2022-08-03 | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | Shares withheld for taxes | −4,562 | $1.32 | $6K | 26,134 |
| 2022-08-02 | Guerin Mark Patrick CFO AND COO | Option exercise | +4,750 | 14,431 | ||
| 2022-08-02 | Guerin Mark Patrick CFO AND COO | Option exercise · Restricted Stock Units | −4,750 | 9,500 | ||
| 2022-08-02 | Gelder Mark S. MD CHIEF MEDICAL OFFICER | Option exercise | +4,650 | 7,031 | ||
| 2022-08-02 | Gelder Mark S. MD CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −4,650 | 9,300 | ||
| 2022-08-02 | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | Option exercise | +12,566 | 30,696 | ||
| 2022-08-02 | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | Option exercise · Restricted Stock Units | −12,566 | 25,134 | ||
| 2022-06-10 | Guerin Mark Patrick COO and CFO | Grant or award · Stock Option (right to purchase) | +50,250 | 50,250 | ||
| 2022-06-10 | Guerin Mark Patrick COO and CFO | Grant or award · Restricted Stock Units | +16,500 | 16,500 | ||
| 2022-02-07 | Gelder Mark S. MD Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +51,750 | 51,750 | ||
| 2022-02-07 | Gelder Mark S. MD Chief Medical Officer | Grant or award · Restricted Stock Units | +17,500 | 17,500 |
Page 8 of 9 · 170 trades